Literature DB >> 7596998

Isothermal and nonisothermal decomposition of famotidine in aqueous solution.

G H Junnarkar1, S Stavchansky.   

Abstract

The kinetics of hydrolysis of famotidine in aqueous solution was studied by isothermal and nonisothermal method over the pH range of 1.71 to 10.0. Nonisothermal kinetics was studied with the purpose of determining its use in the establishment of the expiration date of pharmaceutical preparations, particularly drugs in solutions and for assessment of stability characteristics of pharmaceutical formulations during the development stage. A comparison of isothermal (55, 70 and 85 degrees C) and nonisothermal kinetics was performed. Aqueous solutions of famotidine were buffered at pH 1.71, 2.24, 2.66, 4.0, 8.5, 9.0 and 10.0 were used. In the nonisothermal studies, the temperature rate of the reaction was continuously varied throughout the experiment. The energies of activation were found to be in close agreement for isothermal and nonisothermal studies, indicating that nonisothermal studies may save considerable amount of time in the early stages of drug development and stability testing. Logk-pH profiles were constructed for 55, 70 and 85 degrees C from the first-order rate constants obtained from isothermal studies at pH values ranging from 1.71 to 10.00. The pH-rate profile indicated that famotidine undergoes specific acid catalysis in the acidic region and general base catalysis in the alkaline region. Hydrolysis in the acidic and alkaline media resulted in the formation of four and five degradation products, respectively. A possible degradation pathway for the acidic and alkaline hydrolysis was discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7596998     DOI: 10.1023/a:1016222501079

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  7 in total

1.  AN ACCELERATED STORAGE TEST WITH PROGRAMMED TEMPERATURE RISE.

Authors:  A R ROGERS
Journal:  J Pharm Pharmacol       Date:  1963-12       Impact factor: 3.765

2.  Nonisothermal stability assessment of stable pharmaceuticals: testing of a clindamycin phosphate formulation.

Authors:  J E Kipp; J J Hlavaty
Journal:  Pharm Res       Date:  1991-05       Impact factor: 4.200

3.  Estimation of the stability of dry horse serum cholinesterase by means of an accelerated storage test.

Authors:  B R Cole; L Leadbeater
Journal:  J Pharm Pharmacol       Date:  1968-01       Impact factor: 3.765

4.  Nonisothermal kinetics applied to drugs in pharmaceutical suspensions.

Authors:  J O Waltersson; P Lundgren
Journal:  Acta Pharm Suec       Date:  1983

5.  Nonisothermal kinetics applied to pharmaceuticals.

Authors:  J O Waltersson; P Lundgren
Journal:  Acta Pharm Suec       Date:  1982

6.  Nonisothermal kinetics with programmed temperature steps.

Authors:  B Edel; M O Baltzer
Journal:  J Pharm Sci       Date:  1980-03       Impact factor: 3.534

7.  Estimation of all parameters from nonisothermal kinetic data.

Authors:  I G Tucker; W R Owen
Journal:  J Pharm Sci       Date:  1982-09       Impact factor: 3.534

  7 in total
  1 in total

1.  Design of 3-aminophenol-grafted polymer-modified zinc sulphide nanoparticles as drug delivery system.

Authors:  Milad Abniki; Zahra Azizi; Homayon Ahmad Panahi
Journal:  IET Nanobiotechnol       Date:  2021-06-11       Impact factor: 2.050

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.